Myriad Genetics DTC Ads For BRACAnalysis To Focus On Prevention Market
This article was originally published in The Gray Sheet
Executive Summary
Myriad Genetics will concentrate direct-to-consumer advertising in Atlanta and Denver for its BRACAnalysis breast and ovarian cancer genetic predisposition testing service as the firm moves beyond physician education as a sole means of promotion